(Q42701853)

5 November 2017

Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway (English)

1 reference

5 November 2017

0 references

1 reference

Hui Chang

13

0 references

author name string

Yong Zhang

1

1 reference

5 November 2017

Ming-liang Chen

2

1 reference

5 November 2017

Yong Zhou

3

1 reference

5 November 2017

Long Yi

4

1 reference

5 November 2017

Yan-xiang Gao

5

1 reference

5 November 2017

Li Ran

6

1 reference

5 November 2017

Shi-hui Chen

7

1 reference

5 November 2017

Ting Zhang

8

1 reference

5 November 2017

Xi Zhou

9

1 reference

5 November 2017

Dan Zou

10

1 reference

5 November 2017

Bin Wu

11

1 reference

5 November 2017

Ying Wu

12

1 reference

5 November 2017

Jun-dong Zhu

14

1 reference

5 November 2017

Qian-yong Zhang

15

1 reference

5 November 2017

Man-tian Mi

16

1 reference

5 November 2017

28 May 2015

1 reference

Molecular Nutrition and Food Research

5 November 2017

1 reference

5 November 2017

59

1 reference

5 November 2017

8

1 reference

5 November 2017

1443-1457

1 reference

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

5 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Nonalcoholic fatty liver disease: current and potential therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Phenotyping the effect of diet on non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

The role of diet and nutrient composition in nonalcoholic Fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Resveratrol inhibits nonalcoholic fatty liver disease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Functions of autophagy in hepatic and pancreatic physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

p73 regulates autophagy and hepatocellular lipid metabolism through a transcriptional activation of the ATG5 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Dengue virus-induced autophagy regulates lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Resveratrol-induced autophagocytosis in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Sirt1 protects against high-fat diet-induced metabolic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Methods in mammalian autophagy research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

SREBPs: metabolic integrators in physiology and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

AMPK in cardiovascular health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Cell biology: Another way to get rid of fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Autophagy regulates lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Resveratrol: its biologic targets and functional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Distinct effects of calorie restriction and resveratrol on diet-induced obesity and Fatty liver formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Finding a target for resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis In 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD(+).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Chemistry, stability and bioavailability of resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

Determination oftrans-Resveratrol in Plasma by HPLC

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500016

21 January 2018

Identifiers

DOI

10.1002/MNFR.201500016

1 reference

5 November 2017

1 reference